slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 93,241-93,270
Pages 3,683
Rows per page 30
Component
93,241-93,270 of 110,471
06
The slide uses a timeline to show the progression from global strategy execution to product approval, complemented by a list of 2024 milestones.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
07
The slide uses a split layout with a left-hand sidebar for advisors/board and a right-hand grid for the leadership team.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
11
The slide uses a bar chart to segment the $3.1B market into specific drugs and categories.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizeLoop · Pattern Hunter1 hit
15
The slide uses a split-screen layout to contrast in vitro potency (dot plot) with in vivo efficacy (bar chart).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
21
Swimmer plot showing patient-level treatment duration with ongoing status and response markers.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
23
Data cut-off: 8 Aug 2023. Source: Lin J.J. et al., AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
The chart shows pharmacokinetic data across five dose cohorts, demonstrating that the 150mg dose consistently stays above the predicted CNS efficacy thresholds.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
26
Includes a detailed table of patient cohorts and study objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
33
Includes a summary table of ORR and a waterfall plot of tumor regression.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
35
Data as of 13 Sep 2022. Includes list of specific adverse events by grade.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
36
RP2D = Recommended Phase 2 Dose; QD = once daily; MTD = Maximum Tolerated Dose.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
38
The slide outlines a multi-cohort study design with specific patient populations (TKI-naive vs pre-treated) and objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
41
The slide uses a timeline framework to connect current clinical program statuses to a future milestone.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
07
The slide highlights a specific publication in the AJHP as a standard reference.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), EnlivenHealth solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software solutions.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
12
The slide uses a grouped bar chart to compare financial positions across two time periods.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
16
Includes a disclaimer regarding non-GAAP reconciliation and a definition of bookings.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
01
Orbia | Results Presentation Deck | 10 slidesOrbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · Attention1 hit
03
Orbia | Results Presentation Deck | 10 slidesOrbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
04
Includes a waterfall chart for net debt reconciliation.Orbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
Includes a waterfall chart showing the movement of net debt from Q4 2022 to Q4 2023.Orbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Orbia | Results Presentation Deck | 10 slidesOrbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
Orbia | Results Presentation Deck | 10 slidesOrbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations Beat · Action1 hit
10
Corporate identity slide.Orbia | Results Presentation Deck | 10 slides · Orbia
Conference presentation Investor relations 1 hit
09
The slide showcases four specific medical device products categorized into two therapy types.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Solution1 hit
11
The slide highlights a TTM revenue of $733M with a breakdown of 28% Bone Growth Therapies, 57% Spinal Implants/Biologics/Enabling Tech, and 15% Orthopedics, alongside an 83/17 US/OUS split.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations 1 hit
13
The slide uses a grid layout to present distinct business growth drivers.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
17
Orthofix | Investor Presentation Deck | 22 slidesOrthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
09
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · Team1 hit
17
The slide uses a horizontal arrow to suggest an integrated or continuous approach across the four pillars.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations 1 hit